The US Food and Drug Administration and not-for-profit organization, the Reagan-Udall Foundation, are exploring a proposed tool that could make it easier for physicians and patients seeking access to unapproved drugs by providing a central repository of information about biopharma manufacturers' policies and points of contact1,2.
However, the proposal for the tool, known as the Expanded Access Navigator, requires strong support from manufacturers for it to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?